News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Corinne Faivre-Finn: An International EORTC Survey on Stage III NSCLC resectability
Corinne Faivre-Finn/LinkedIn
Dec 27, 2024, 17:00

Corinne Faivre-Finn: An International EORTC Survey on Stage III NSCLC resectability

Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology at the University of Manchester, posted on X about recent paper by her as co-author, titled “An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer” published on Lung Cancer Journal.

Authors: Ilias Houda, Idris Bahce, Chris Dickhoff, Tiuri E. Kroese, Stephanie G.C. Kroeze, Alessio V. Mariolo, Marco Tagliamento, Laura Moliner, Mariana Brandao, Yassin Pretzenbacher, John Edwards, Isabelle Opitz, Alessandro Brunelli, Matthias Guckenberger, Paul E. van Schil, Sanjay Popat, Torsten Blum, Corinne Faivre-Finn, Dirk de Ruysscher, Jordi Remon, Thierry Berghmans, Anne-Marie C. Dingemans, Benjamin Besse, Lizza E.L. Hendriks.

Corinne Faivre-Finn: An International EORTC Survey on Stage III NSCLC resectability

“An International EORTC Survey on Stage III NSCLC resectability:
Resectable:

  • Smaller tumors, with single-station N2
  • Larger tumors, with max N1

Unresectable:

  • Bulky/invasive N2, N3
  • T4 tumors, with multi-station N2
  • Results shaped a consensual definition.”
Alessandro Brunelli Alessio V. Mariolo Anne-Marie C. Dingemans Benjamin Besse cancer Chris Dickhoff Corinne Faivre-Finn Dirk de Ruysscher EORTC Idris Bahce Ilias Houda Isabelle Opitz John Edwards Jordi Remon Laura Moliner Lizza E. L. Hendriks Lung Cancer Journal Marco Tagliamento Mariana Brandao Matthias Guckenberger NSCLC OncoDaily Oncology Paul E. Van Schil Sanjay Popat Stephanie G.C. Kroeze Thierry Berghmans Tiuri E. Kroese Torsten Blum Yassin Pretzenbacher
Special Coverage
Blog
Apr 23, 2025, 01:36
90-min ESTRO Webinar on early HPV+ oropharyngeal cancer - ESTRO
Blog
Apr 22, 2025, 19:24
Esra Bilir: Great pleasure and honor to interview Nadeem Abu-Rustum
Blog
Apr 22, 2025, 18:41
Nurses Community of Practice and GPON Spotlight Advocacy in Precision Oncology - FT3
Blog
Apr 22, 2025, 18:28
Vidith Phillips: AI x Oncology - Research Highlights Shaping Cancer Care in 2025
Blog
Apr 22, 2025, 18:02
Afreen Shariff: Fatigue is not just a side effect - it’s a serious complex, and often overlooked challenge in cancer care
Blog
Apr 22, 2025, 17:31
Vivek Subbiah: It's moments like these that remind me why I do what I do
Positive
Apr 22, 2025, 17:21
Foundation S marks 20 years of impact through My Child Matters - Childhood Cancer International
Blog
Apr 22, 2025, 17:11
Lisa A. Lacasse: We’re able to elevate the patient voice in the fight against cancer at every level of government
Blog
Apr 22, 2025, 17:05
Paul Ekert presents ZERO program at St. Jude Symposium - Children's Cancer Institute
Blog
Apr 22, 2025, 16:58
Wafik S. El-Deiry: Best Practices for Sponsored Research event
Opinion
Apr 22, 2025, 16:42
Nathan Pennell: The Medical community needs to oppose the Department of Justice's threats to journal independence
Blog
Apr 22, 2025, 16:28
Ruben Mesa: Celebrating the extraordinary 27 year tenure of Bayard Powell as the Chief of Hematology and Medical Oncology